Award notice Supplies
Raamovereenkomst voor de levering van dexmedetomidine
Notice published in Dutch. The AI analysis summarises it for you in your language.
- Public buyer
- Hospilim VZW
Diepenbeek - Place of performance
- 3590 Diepenbeek, Limburg
not published: buyer's address - Bids received
- 2
- Form
- Framework agreement
Multi-year contract: the buyer places orders as needs arise. - Procedure
- Negotiated procedure without prior publication
The buyer consulted a few companies directly: it is no longer possible to take part. - Publication
- 24 December 2024
- Notice language
- Dutch
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
Teneinde te kunnen beantwoorden aan de continue en desgevallend dringende behoefte tot aanschaf van dexmedetomidine, wenst HospiLim over te gaan tot het afsluiten van een raamovereenkomst met één opdrachtnemer.
Awarded to
- ORION PHARMA BCE/KBO 0821.527.741
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33661000 33661100
Similar contracts already awarded
| Contract | Winner | Amount |
|---|---|---|
| Raamovereenkomst voor de levering van geneesmiddelen voor lokale anesthetica, narcotica en curarisantia Hospilim VZW · 30 September 2024 |
Laboratoires Sterop Fresenius Kabi Viatris sandoz B. BRAUN MEDICAL |
– |
| Raamovereenkomst voor de levering van psychofarmaca Hospilim VZW · 8 January 2024 |
Eurogenerics nv Arega Pharma bv GlaxoSmithKline Pharmaceuticals nv Viatris bv Janssen Cilag nv |
€2,719,170 |
| Sevofluraan AZ Delta vzw · 13 October 2026 |
Abbvie NV | €1,075,340 |
| Raamovereenkomst voor het leveren van anesthetica Universitair Ziekenhuis Gent · 24 September 2026 |
PFIZER PFE BELGIUM SPRL Fresenius Kabi NV/SA ORION PHARMA BENELUX Grindeks Kalceks Belgium |
€1,696,355 |
| Raamovereenkomst voor het leveren van geneesmiddelen tegen pijn, koorts en osteo-articulaire aandoeningen Universitair Ziekenhuis Gent · 7 September 2026 |
Arega Pharma Fresenius Kabi NV/SA WillPharma Viatris bv |
€1,516,053 |
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 794624-2024.